Global Neurological Disorder Diagnostics Market 2021 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Neurological Disorder Diagnostics Market 2021 (Includes Business Impact of COVID-19)
Global Neurological Disorder Diagnostics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global neurological disorder diagnostics market report has been segmented on the basis of technology, disease indication, end user, and region.
Request Covid - 19 Impact

The global Neurological Disorder Diagnostics market size was valued at USD $13047.34 million in 2020 and is projected to reach USD $26732.93 million by 2030, and is anticipated to expand at a CAGR of 7.43% over the forecast period from 2020 to 2030.


Global Neurological Disorder Diagnostics Market: Overview


Neurological disorder diagnostic tools are medical devices used in diagnosis of various neurological disorders such as Alzheimers disease (AD), Multiple Sclerosis, and Parkinsons disease (PD). It can be diagnosed by imaging and in vitro diagnostics techniques. Imaging techniques such as Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), etc., are used to create detailed images of bones, organs, blood vessels, soft tissue, and in-vitro diagnostic techniques such as biopsy, biomarker, etc.


Global Neurological Disorder Diagnostics Market: Dynamics


Innovative product launches and approvals of novel neurological diagnostic products is a key factor expected to drive growth of the global market over the forecast period. For instance, in April 2018, Siemens Healthineers received US FDA approval -SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems.

In addition, increasing research and development activities in order to develop new diagnosis techniques for neurological disorder and strategic collaboration and acquisition activities among manufacturers operating in the global market for enhance product portfolio and global presence are some major factors expected to further fuel growth of the target market over the forecast period. For instance, in March 2018, three companies namely: Canon Medical Systems, Kumamoto University, and University of Bordeaux are entered into collaborative research for development of deep learning technology in magnetic resonance imaging.

However, high cost of diagnostic imaging tools such as MRI machines and CT scan is a key factor expected to restrain growth of the global market over the forecast period.

Currently, increasing adoption of biomarkers in order to diagnose various diseases is ongoing trend observed in the global market, which is expected to support growth of the target market over the forecast period.

Ongoing technological advancements and innovative product launches are expected to create potential revenue opportunities for players operating in the target market over the forecast period.


Global Neurological Disorder Diagnostics Market: Segment Analysis


Among technology, the imaging technology segment is expected to register significant share in terms of revenue over the forecast period, owing to growing awareness of various imaging technologies among people.

Among end user, the hospitals & clinics segment is expected to register highest growth in terms of revenue over the forecast period, owing to availability of advanced treatment facilities.


Global Neurological Disorder Diagnostics Market: Regional Analysis


The market in North America is expected to dominate in the global market and is expected to continue its dominance over the forecast period, owing to increasing adoption new medical devices and well developed healthcare infrastructure across various countries in the region. The market in Europe is expected to register second-highest share in terms of revenue over the forecast period, owing to technological advancements and innovative product launches in countries in this region. The market in Asia Pacific is expected to register significant growth in terms of revenue over the forecast period, owing to increasing patient pool, rising awareness regarding the availability of advanced treatments, and improving healthcare infrastructure across various countries in the region. The market in Latin America, Middle East and Africa are expected to accounted for moderate growth in the global market over the forecast period.

Global Neurological Disorder Diagnostics Market Segmentation:

Segmentation by technology:

  
Imaging
  
Computed Tomography (CT)
  
Magnetic Resonance Imaging (MRI)
  
Nuclear Medicine Imaging
  
Positron Emission Tomography (PET)
  
Single-Photon Emission Computed Tomography (SPECT)
  
Others [Near Infrared Spectroscopic Imaging (NIRS), Electroencephalography (EEG),
  
Magnetoencephalography (MEG)]
  
In Vitro Diagnostics
  
Biomarker
  
Biopsy

Segmentation by disease indication:

  
Genetic Neurological Disorders
  
Alzheimers Disease (AD)
  
Parkinsons Disease (PD)
  
Others [Amyotrophic Lateral Sclerosis (ALS), Huntingtons Disease (HD)]
  
Immunological Neurological Disorders
  
Paraneoplastic Syndrome
  
Paraproteinemic neuropathies

Segmentation by end user:

  
Hospitals
  
Specialty Clinics
  
Diagnostic Centers
  
Ambulatory Care Centers


Key Market Players included in the report:


  
Abbott Laboratories
  
Advanced Brain Monitoring
  
Boston Scientific Corporation
  
Canon Medical Systems Corporation
  
Esaote SpA
  
General Electric Company
  
Johnson & Johnson
  
Koninklijke Philips N.V.
  
Lifelines Neuro Company, LLC
  
Masimo Corporation
  
Medtronic, Inc.
  
Natus Medical Incorporated
  
NeuroLogica Corporation
  
Neusoft Medical Systems Co., Ltd.
  
Nihon Kohden Corporation
  
Siemens Healthineers, Inc.
  
Smith & Nephew, Inc.
  
Thermo Fisher Scientific, Inc.
  
York Instruments Ltd.